FDA Orange Book · active-ingredient family
Goserelin acetate
Goserelin acetate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ZOLADEX · NDA 020578
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · implant
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZOLADEXRLD | TERSERA | NDA 020578 | — | Jan 11, 1996 | |
| ZOLADEXRLD | TERSERA | NDA 019726 | — | Dec 29, 1989 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Goserelin acetate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

